Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It works by blocking the SGLT2 protein, which prevents the kidneys from reabsorbing glucose into the bloodstream. This results in the excretion of glucose in the urine, which lowers blood sugar levels.Additional information:Empagliflozin may increase the risk of dehydration, especially when used in combination with other medications that can cause dehydration, such as diuretics.Empagliflozin may also increase the risk of serious urinary tract infections.It is important to drink plenty of fluids and to monitor your blood sugar levels closely when taking empagliflozin.Please note: This is just a general overview of empagliflozin. For more detailed information, please consult your doctor or pharmacist.